TETRACYCLINE REPRESSOR PROTEIN CLASS B FROM TRANSPOSON TN1 0
ESCHERICHIA COLI
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein homooligomer Homooligomer Protein × 2 PDB declaration: dimeric(2) Consistent with protein copy count | Chain A; UniProt 2–203 | Not recorded | MIY (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2- CARBOXAMIDE × 2 MG MAGNESIUM ION × 2 PO4 PHOSPHATE ION × 4 | X-RAY DIFFRACTION X-ray crystallization conditions:pH 6.5;pH 6.5 | Resolution 2.45 Å R-free 0.294 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 4AC0 | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 2NS7 How an in vitro selected peptide mimics the antibiotic tetracycline to induce TET repressor Deposited 2006-11-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–187(187 aa)
Chain B
1–187(187 aa)
|
Mutation:C68S, C88N, C121T, C144S Mutation:C68S, C88N, C121T, C144S | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;292 K;1.4M ammonium sulfate, 0.1M sodium chloride, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 2.40 Å R-free 0.277 |
| 2NS7 How an in vitro selected peptide mimics the antibiotic tetracycline to induce TET repressor Deposited 2006-11-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
1–187(187 aa)
Chain D
1–187(187 aa)
|
Mutation:C68S, C88N, C121T, C144S Mutation:C68S, C88N, C121T, C144S | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;292 K;1.4M ammonium sulfate, 0.1M sodium chloride, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 2.40 Å R-free 0.277 |
| 2NS8 How an in vitro selected peptide mimics the antibiotic tetracycline to induce TET repressor Deposited 2006-11-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 5 PDB declaration: pentameric |
Chain A
1–187(187 aa)
Chain B
1–187(187 aa)
|
Mutation:C68S, C88N, C121T, C144S Mutation:C68S, C88N, C121T, C144S | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.8;292 K;4M sodium formate, 0.1M Tris-HCl, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 2.55 Å R-free 0.270 |
| 2NS8 How an in vitro selected peptide mimics the antibiotic tetracycline to induce TET repressor Deposited 2006-11-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Insufficient information Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain C
1–187(187 aa)
Chain D
1–187(187 aa)
|
Mutation:C68S, C88N, C121T, C144S Mutation:C68S, C88N, C121T, C144S | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.8;292 K;4M sodium formate, 0.1M Tris-HCl, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 2.55 Å R-free 0.270 |
| 2NS8 How an in vitro selected peptide mimics the antibiotic tetracycline to induce TET repressor Deposited 2006-11-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Insufficient information Heteromer;Protein × 9 PDB declaration: nonameric |
Chain A
1–187(187 aa)
Chain B
1–187(187 aa)
Chain C
1–187(187 aa)
Chain D
1–187(187 aa)
|
Mutation:C68S, C88N, C121T, C144S Mutation:C68S, C88N, C121T, C144S Mutation:C68S, C88N, C121T, C144S Mutation:C68S, C88N, C121T, C144S | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.8;292 K;4M sodium formate, 0.1M Tris-HCl, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 2.55 Å R-free 0.270 |
| 2VKV TetR (BD) variant L17G with reverse phenotype Deposited 2008-01-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–50(50 aa)
Fragment:RESIDUES 1-50,51-208
|
Mutation:YES | TDC 5A,6-ANHYDROTETRACYCLINE × 2 MG MAGNESIUM ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.7;277 K;0.1 M TRIS-HCL (PH 8.7), 0.3 M MGCL2, 20 % PEG 4000, 3 % DIOXANE, AT 277 K
|
Resolution 1.74 Å R-free 0.225 |
| 2XGC Crystal structure of a designed heterodimeric variant T-A(I)B of the tetracycline repressor Deposited 2010-06-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–50(50 aa)
Fragment:RESIDUES 1-50,51-208
|
Mutation:YES | No recorded non-water small molecule | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.15 Å R-free 0.271 |
| 2XGC Crystal structure of a designed heterodimeric variant T-A(I)B of the tetracycline repressor Deposited 2010-06-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain B
1–50(50 aa)
Fragment:RESIDUES 1-50,51-208
|
Mutation:YES | No recorded non-water small molecule | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.15 Å R-free 0.271 |
| 2XGD Crystal structure of a designed homodimeric variant T-A(L)A(L) of the tetracycline repressor Deposited 2010-06-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–50(50 aa)
Fragment:RESIDUES 1-50,51-208
|
Mutation:YES | CL CHLORIDE ION × 2 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.25 Å R-free 0.259 |
| 2XGE Crystal structure of a designed heterodimeric variant T-A(A)B of the tetracycline repressor Deposited 2010-06-03 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–50(50 aa)
Fragment:RESIDUES 1-50,51-208
|
Not recorded | EDO 1,2-ETHANEDIOL × 2 NA SODIUM ION × 2 CL CHLORIDE ION × 2 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.14 Å R-free 0.260 |
| 2XGE Crystal structure of a designed heterodimeric variant T-A(A)B of the tetracycline repressor Deposited 2010-06-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain B
1–50(50 aa)
Fragment:RESIDUES 1-50,51-208
|
Mutation:YES | No recorded non-water small molecule | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.14 Å R-free 0.260 |
| 3FK6 Crystal structure of TetR triple mutant (H64K, S135L, S138I) Deposited 2008-12-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–50(50 aa)
Fragment:DNA-binding domain (residues 1-50) and the effector-binding domain (residues 51-208)
Chain B
1–50(50 aa)
Fragment:DNA-binding domain (residues 1-50) and the effector-binding domain (residues 51-208)
|
Mutation:H64K, S135L, S138I Mutation:H64K, S135L, S138I | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;292 K;1M dipotassium hydrogen phosphate, 200mM sodium chloride, 50mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 2.10 Å R-free 0.262 |
| 3FK7 Crystal structure of TetR triple mutant (H64K, S135L, S138I) in complex with 4-ddma-atc Deposited 2008-12-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–50(50 aa)
Fragment:DNA-binding domain (residues 1-50) and the effector-binding domain (residues 51-208)
Chain B
1–50(50 aa)
Fragment:DNA-binding domain (residues 1-50) and the effector-binding domain (residues 51-208)
|
Mutation:H64K, S135L, S138I Mutation:H64K, S135L, S138I | MG MAGNESIUM ION × 2 4DM (4aS,12aS)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;292 K;1M dipotassium hydrogen phosphate, 200mM sodium chloride, 50mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 2.06 Å R-free 0.261 |
| 3ZQF Structure of Tetracycline repressor in complex with antiinducer peptide-TAP1 Deposited 2011-06-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–187(187 aa)
Fragment:RESIDUES 1-187,188-208
|
Mutation:YES | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;RESERVOIR: 3 M NACL, 0.1 M BIS-TRIS, PH 6.
|
Resolution 2.56 Å R-free 0.247 |
| 3ZQG Structure of Tetracycline repressor in complex with antiinducer peptide-TAP2 Deposited 2011-06-09 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–187(187 aa)
Fragment:RESIDUES 1-187,188-208
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;RESERVOIR: 3 M NACL, 0.1 M BIS-TRIS, PH 6.5
|
Resolution 2.45 Å R-free 0.234 |
| 3ZQH Structure of Tetracycline repressor in complex with inducer peptide- TIP3 Deposited 2011-06-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–187(187 aa)
Fragment:RESIDUES 1-187,188-208
|
Mutation:YES | EDO 1,2-ETHANEDIOL × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 9;0.2 M NACL, 0.1 M TRIS PH 9.0, 25% PEG 3350.
|
Resolution 1.60 Å R-free 0.224 |
| 3ZQI Structure of Tetracycline repressor in complex with inducer peptide- TIP2 Deposited 2011-06-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–187(187 aa)
Fragment:RESIDUES 1-187,188-208
Chain B
1–187(187 aa)
Fragment:RESIDUES 1-187,188-208
|
Mutation:YES Mutation:YES | EDO 1,2-ETHANEDIOL × 5 MG MAGNESIUM ION × 1 PG4 TETRAETHYLENE GLYCOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;0.2 M MAGNESIUM ACETATE, 0.1 M SODIUM CACODYLATE, PH 7.0, 20% PEG 8000.
|
Resolution 1.50 Å R-free 0.195 |
| 6SY4 TetR in complex with the TetR-binding RNA-aptamer K1 Deposited 2019-09-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein–RNA Homooligomer;Protein × 2 PDB declaration: trimeric |
Chain A
1–203(203 aa)
Chain B
1–203(203 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293 K;4% v/v Tacsimate pH 6.0, 12% w/v PEG 3350
|
Resolution 2.69 Å R-free 0.246 |
| 6SY6 TetR in complex with the TetR-binding RNA-aptamer K2 Deposited 2019-09-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein–RNA Homooligomer;Protein × 2 PDB declaration: trimeric |
Chain A
1–203(203 aa)
Chain B
1–203(203 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293 K;15 % (v/v) pentaerythritol propoxylate (5/4 PO/OH), 0.2 M NaCl, pH 6.0, 0.1 M MES-NaOH
|
Resolution 2.90 Å R-free 0.288 |
| 9DT3 Crystal structure of the engineered sulfonylurea repressor EsR (L11-C6), bound to ethametsulfuron-methyl Deposited 2024-09-30 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–207(207 aa)
Chain B
1–207(207 aa)
|
Not recorded | RXF methyl 2-[[4-ethoxy-6-(methylamino)-1,3,5-triazin-2-yl]carbamoylsulfamoyl]benzoate × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.05 M Magnesium chloride
0.1 M HEPES pH 7.5
30% v/v Polyethylene glycol monomethyl ether 550
|
Resolution 2.80 Å R-free 0.278 |
| 9DT3 Crystal structure of the engineered sulfonylurea repressor EsR (L11-C6), bound to ethametsulfuron-methyl Deposited 2024-09-30 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
1–207(207 aa)
Chain D
1–207(207 aa)
|
Not recorded | RXF methyl 2-[[4-ethoxy-6-(methylamino)-1,3,5-triazin-2-yl]carbamoylsulfamoyl]benzoate × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.05 M Magnesium chloride
0.1 M HEPES pH 7.5
30% v/v Polyethylene glycol monomethyl ether 550
|
Resolution 2.80 Å R-free 0.278 |
| 9DT4 Crystal structure of the engineered sulfonylurea repressor CsR (L4.2-20), apo form Deposited 2024-09-30 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–207(207 aa)
Chain B
1–207(207 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.2 M Sodium acetate
0.1 M TRIS hydrochloride pH 8.5
30% w/v Polyethylene glycol 4,000
|
Resolution 2.40 Å R-free 0.241 |
| 9DT5 Crystal structure of the engineered sulfonylurea repressor CsR (L4.2-20), bound to chlorsulfuron Deposited 2024-09-30 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–207(207 aa)
Chain B
1–207(207 aa)
|
Not recorded | 1CS 1-(2-CHLOROPHENYLSULFONYL)-3-(4-METHOXY-6-METHYL-L,3,5-TRIAZIN-2-YL)UREA × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.05 M Ammonium sulfate
0.05 M BIS-TRIS pH 6.5
30% w/v Polyethylene glycol 600
|
Resolution 2.00 Å R-free 0.228 |
| 9DT5 Crystal structure of the engineered sulfonylurea repressor CsR (L4.2-20), bound to chlorsulfuron Deposited 2024-09-30 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
1–207(207 aa)
Chain D
1–207(207 aa)
|
Not recorded | 1CS 1-(2-CHLOROPHENYLSULFONYL)-3-(4-METHOXY-6-METHYL-L,3,5-TRIAZIN-2-YL)UREA × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.05 M Ammonium sulfate
0.05 M BIS-TRIS pH 6.5
30% w/v Polyethylene glycol 600
|
Resolution 2.00 Å R-free 0.228 |
17 other PDB entries and 24 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | TETR2_ECOLX |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–202; UniProt 2–203 |